Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: HIV Postexposure Prophylaxis With Darunavir/r (PEPDar)
Brief Summary: The primary purpose of this study is to assess the rate of early discontinuation from randomized Human Immunodeficiency Virus (HIV) Postexposure Prophylaxis (PEP) for any reason other than confirmation of the negative HIV infection status of the index person in patients receiving HIV PEP for at least 28 and a maximum of 30 days.